Livzon Pharmaceutical Group Inc. (01513) said its net profit attributable to shareholders of the company was RMB738.95 million for the six months ended 30 June 2019, a year-on-year increase of 16.67%. The earnings per share were RMB1.03. No dividend will be distributed.
The operating income was RMB4.94 billion, a year-on-year increase of 8.2%.
WoW WoW星期三：健康網購產品低至$99 (只限今天)► 立即行動
